Skip to main content

Published locations for Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects

User login

  • Reset your password
  • /content/rozlytrek-approved-ros1-positive-metastatic-nsclc-cancers-ntrk-gene-fusion-defects
  • /oncologypractice/article/206542/lung-cancer/rozlytrek-approved-ros1-positive-metastatic-nsclc
  • /sarcomajournal/article/206542/lung-cancer/rozlytrek-approved-ros1-positive-metastatic-nsclc-cancers
  • /hematology-oncology/article/206542/lung-cancer/rozlytrek-approved-ros1-positive-metastatic-nsclc